We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Lysosomal Activity Changes as Dendritic Cells Mature

By Biotechdaily staff writers
Posted on 24 Mar 2003
Researchers have found that as dendritic cells mature, a physiologic change occurs in their lysosomes, digestive vacuoles within the cytoplasm that facilitate the efficient formation of peptide-MHC class II complexes on the surface of the cells. More...
Their findings were published in the March 7, 2003, issue of Science.

Dendritic cells are the most potent antigen-presenting cells involved in host defense. All immunogenic and tolerogenic responses are initiated upon the recognition of antigen presented by mature dendritic cells, playing an important role in the immune response in cancer and autoimmune diseases.

In response to a variety of stimuli, dendritic cells transform from immature cells specialized for antigen capture into mature cells specialized for T cell stimulation. The physiologic basis of this maturation process was not well understood.

In the current study, investigators from Yale University's Ludwig Cancer Institute (New Haven, CT, USA; www.yale.edu) showed that dendritic cell maturation was accompanied by an acidic shift in lysosomes that favored the production of immune stimulating molecules. In general, lysosomes quickly destroy internalized proteins from bacteria, viruses, or cancer cells and then convert them into individual amino acids that are too small to be recognized by the immune system. However, in mature dendritic cells antigens are sequestered in the lysosomes and then degraded into peptide fragments that are 10-to-15 amino acids in length. These fragments then bind to other molecules, which transport them from lysosomes to the surface of cells.

"Despite rather unfavorable conditions, mature dendritic cells are able to use their lysosomes to warn the immune system,” explained senior author Dr. Ira Mellman, a researcher in the department of cell biology at Yale University School of Medicine. "For 50 years, we have been taught that lysosomes simply degrade all protein they encounter, a situation which would prevent the formation of the large protein fragments required to generate immunity. Dendritic cells have contrived a way around the conventional view of lysosomes by controlling their activities.”

"The fact that lysosomes appear developmentally controlled would explain a key feature of why dendritic cells are so good at what they do,” added Dr. Mellman.

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.